Regulatory News In Brief
This article was originally published in The Gray Sheet
Executive Summary
FDA issues procedures governing reviewers' requests for additional pre-market data from sponsors. Agency extends comment period for its de novo and 510(k) modification draft guidances. More regulatory briefs.
You may also be interested in...
Regulatory News In Brief
FDA delivers first report on foreign offices to Congress. Agency denies citizen petition on IOM 510(k) panel. More regulatory briefs.
New FDA Policies Aim To Ease Midstream Reviewer Changes (But Will They Really Help?)
The jury is still out on whether CDRH’s new standard operating procedures will improve continuity when a review team changes midstream.